Difference between revisions of "Team:Evry Paris-Saclay/Improve"

 
(20 intermediate revisions by 3 users not shown)
Line 3: Line 3:
 
<head>
 
<head>
 
<style>
 
<style>
 +
figure img{
 +
    width:80%;
 +
}
 +
 +
figure{
 +
    margin-top:20px;
 +
    margin-bottom:20px;
 +
    margin-left:auto;
 +
    margin-right:auto;
 +
}
 +
 +
figcaption{
 +
    font-size:10px;
 +
}
 +
 
.row {
 
.row {
 
   /*display: flex;
 
   /*display: flex;
Line 27: Line 42:
 
.axel{
 
.axel{
 
   padding-top:15px;
 
   padding-top:15px;
 +
}
 +
 +
table{
 +
  font-size: 12px;
 
}
 
}
  
Line 32: Line 51:
 
</head>
 
</head>
 
<body>
 
<body>
<div class="contentEvry">
+
<div class="contentEvry" style="text-align:center; padding-left:auto; padding-right:auto;">
<h1 style="font-weight:800;">Ecrire le Titre de niveau 1</h1>
+
<!-- dans la balise h1 ou h2 ou h3 écrire le titre de la partie -->
<h2>Titre de niveau 2</h2>
+
<h1 style="font-weight:800; text-align:center;">THE PEPTIDE</h1>
<h3>Titre de niveau 3</h3>
+
<!-- dans la balise p, écrire les longues parties de texte -->
 +
<!-- pour metttre un mot en gras, entourer le mot de la balise <b>mot</b> -->
 
<!-- Ecrire le texte ici -->
 
<!-- Ecrire le texte ici -->
<p style="font-size:15px;">Ecrire le texte ici, Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>
+
<p style="font-size:15px;">In our system, the hexapeptide SAIRGA is the signalling molecule used for cell-to-cell communication [1]. To perform its quorum sensing function in the natural phi3T phage infection, SAIRGA needs to be secreted out of the cell. It is produced as an immature pre-pro-peptide, AimP (<a href="http://parts.igem.org/Part:BBa_K2279001" target="__blank">BBa_K2279001</a>), that upon secretion is cleaved extracellularly to remove the secretion signal and release the mature hexapeptide. The mature peptide then re-enters cells and binds to its receptor protein AimR (<a href="http://parts.igem.org/Part:BBa_K2279000" target="__blank">BBa_K2279000</a>). Binding of SAIRGA to AimR blocks the activator function of AimR that, in turn, facilitates a switch from lytic-to-lysogenic viral cycle. By acting as a negative regulator of AimR, the SAIRGA signal makes the lysis-to-lysogeny switch of phi3T phage dependent on the “quorum” of phi3T phages in the bacterial population.</p></br>
<div class="column full_size judges-will-not-evaluate">
+
<img style="margin-left:auto; margin-right:auto; width:40%;" src="https://static.igem.org/mediawiki/2018/7/78/T--Evry_Paris-Saclay--ThePeptide.png" alt="" /><br/><br/>
<h3>★  ALERT! </h3>
+
<h2 style="font-weight:800; text-align:center;">DESIGN</h2>
<p>This page is used by the judges to evaluate your team for the <a href="https://2018.igem.org/Judging/Medals">medal criterion</a> or <a href="https://2018.igem.org/Judging/Awards"> award listed below</a>. </p>
+
<p style="font-size:15px;">In phi3T phage, SAIRGA is produced as AimP (<a href="http://parts.igem.org/Part:BBa_K2279001" target="__blank">BBa_K2279001</a>) with specific secretion and protease-cleavage tags [1] that allow secretion and extracellular processing by <em>Bacillus</em>. Since we had no further information about this protease, we could not investigate the ability of <em>Escherichia coli</em> to produce a similar enzyme. Consequently, to produce SAIRGA in <em>E. coli</em>, we decided to replace this tag by an <em>E. coli</em> secretion signal. We have investigated three different secretion signals: OmpA (<a href="http://parts.igem.org/Part:BBa_K208003" target="__blank">BBa_K208003</a>), PelB (<a href="http://parts.igem.org/Part:BBa_J32015" target="__blank">BBa_J32015</a>) and Tat of <em>csp2</em> gene of <em>Corynebacterium glutamicum</em> (Uniprot Q04985).</p>
<p> Delete this box in order to be evaluated for this medal criterion and/or award. See more information at <a href="https://2018.igem.org/Judging/Pages_for_Awards"> Instructions for Pages for awards</a>.</p>
+
<p style="font-size:15px;">
</div>
+
To express them in <em>E. coli</em>, we codon optimized all sequences for <em>E. coli</em> DH5α, designed specific RBSs with the Salis Lab RBS Calculator [2, 3] and placed these peptides under the control of the constitutive strong promoter <a href="http://parts.igem.org/Part:BBa_J23100" target="__blank">BBa_J23100</a>. Thus, we generated four SAIRGA expression plasmids (<a href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</a>, <a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>, <a href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</a> and <a href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</a>).</p>
 
+
 
+
<div class="clear"></div>
+
  
 +
<!-- POUR FAIRE UN TABLEAU -->
 +
<table>
 +
  <tr>
 +
      <th style="text-align:center;">Part Name</th>
 +
      <th style="text-align:center;">Translated CDS Sequence</th>
 +
      <th style="text-align:center;">Part Number</th>
 +
      <th style="text-align:center;">Expression Cassette Part Number</th>
 +
  </tr>
 +
  <tr>
 +
      <td>AimP</td>
 +
      <td>MKKVFFGLVILTALAISFVAGQQSVSTASASDEVTVA<font style="color:#FF0000;">SAIRGA</font></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675001" target="__blank">BBa_K2675001</a></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</a></td>
 +
  </tr>
 +
  <tr>
 +
      <td>OmpA-SAIRGA</td>
 +
      <td>MKKTAIAIAVALAGFATVAQA<font style="color:#FF0000;">SAIRGA</font></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675002" target="__blank">BBa_K2675002</a></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a></td>
 +
  </tr>
 +
  <tr>
 +
      <td>PelB-SAIRGA</td>
 +
      <td>MKYLLPTAAAGLLLLAAQPAMA<font style="color:#FF0000;">SAIRGA</font></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675003" target="__blank">BBa_K2675003</a></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</a></td>
 +
  </tr>
 +
  <tr>
 +
      <td>Tat-SAIRGA</td>
 +
      <td>MFNNRIRTAALAGAIAISTAASGVAIPAFA<font style="color:#FF0000;">SAIRGA</font></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675004" target="__blank">BBa_K2675004</a></td>
 +
      <td><a href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</a></td>
 +
  </tr>
 +
</table>
  
<div class="column full_size">
+
<h2 style="font-weight:800; text-align:center;">EXPERIMENTAL SETUP</h2>
<h1>Improve</h1>
+
<p style="font-size:15px;"><em>E. coli</em> DH5α harboring the SAIRGA expression plasmids were grown at 37°C in mineral salts medium [4] containing 2 mg/mL glucose and 35 μg/mL chloramphenicol (Figure 8). During the culturing, samples were prelevated, centrifuged and the supernatant was first sterilised by filtering through a 0.22 µm membrane, then loaded on a Pall Nanosep centrifugal device with Omega membrane (MWCO 3 kDa). The low molecular weight fraction of the culturing media thus recovered was analysed by LC-MS: ultra high pressure liquid column chromatography (UPLC) on a ACQUITY HSS T3  1.8 µM, 2.1 x 100 mm column (Waters) coupled with a Xevo G2-S Qtof mass spectrometer (Waters). The chromatography was performed using a gradient of using a (A) 1% formic acid in whater / (B) 1% formic acid in acetonitrile with the following program: from 0 to 5 min solvent B was increased from 2% to 70%, then it was maintained for 1 min at 70%; aftrewards it was decreased in 30 sec to 2% and it was maintained at 2% for 3.5 min for column re-equilibration. The flow rate was 0.2 mL/min and the column temperature was set to 45°C. The ions were detected in resolution negative mode.</p>
<p>For teams seeking to improve upon a previous part or project, you should document all of your work on this page. Please remember to include all part measurement and characterization data on the part page on the Registry. Please include a link to your improved part on this page.</p>
+
<p style="font-size:15px;">The pure synthetic SAIRGA peptide was readily detected by LC-MS. As shown in Figures 1 and 2, a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- was observed at a retention time of 3.9 min (Figure 3). The area under the curve is proportional to the concentration of SAIRGA (Figure 4).</p>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/2/28/T--Evry_Paris-Saclay--PeptideFigure1.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 1</b>: Mass spectrometry analysis of SAIRGA’s fraction obtained with various amounts of pure synthetic SAIRGA peptide.</figcaption>
 +
</figure>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/c/c2/T--Evry_Paris-Saclay--PeptideFigure2.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 2</b>: Mass spectrometry analysis of SAIRGA’s fraction obtained with 5 µM of pure synthetic SAIRGA peptide (zoom on SAIRGA’s peak).</figcaption>
 +
</figure>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/2/29/T--Evry_Paris-Saclay--PeptideFigure3.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 3</b>: UPLC chromatograms obtained with various amount of pure synthetic SAIRGA peptide. </figcaption>
 +
</figure>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/2/26/T--Evry_Paris-Saclay--PeptideFigure4.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 4</b>: Standard curve of the area under the curve obtained by UPLC as a function of the concentration of SAIRGA.</figcaption>
 +
</figure>
 +
<h2 style="font-weight:800; text-align:center;">RESULTS</h2>
 +
<p style="font-size:15px;">LC-MS analysis of samples isolated from the fermentation broth of the <em>E. coli</em> strains harbouring a SAIRGA expression plasmid was performed.</p>
 +
<p style="font-size:15px;">As shown in Figures 5 and 6, the expression vector of OmpA-SAIRGA (<a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>) is able to produce a compound with a monoisotopic mass a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- at a retention time of 3.9 min. The size or the area under the peak is increasing with time (figure 7). This suggests that OmpA is an efficient <em>E. coli</em> secretion tag which allows the release of the mature peptide SAIRGA in the culturing media.</p>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/4/40/T--Evry_Paris-Saclay--PeptideFigure5.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 5</b>: Mass spectrometry of culturing media taken after 2, 4, 6 and 8 hours of incubation of <em>E. coli</em> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>). The negative control has been performed with an empty pSB1C3 (bottom red chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.</figcaption>
 +
</figure>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/0/0f/T--Evry_Paris-Saclay--PeptideFigure6.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 6</b>: UPLC chromatograms of culturing media taken after 2, 4, 6 and 8 hours of incubation of <em>E. coli</em> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>). The negative control has been performed with an empty pSB1C3 (bottom green chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.</figcaption>
 +
</figure>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/a/a2/T--Evry_Paris-Saclay--PeptideFigure7.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 7</b>: SAIRGA production at 37°C by <em>E. coli</em> cells harboring the various SAIRGA expression plasmids (<a href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</a>, <a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>, <a href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</a> and <a href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</a>). The negative control has been performed with an empty pSB1C3.</figcaption>
 +
</figure>
 +
<figure>
 +
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/7/75/T--Evry_Paris-Saclay--PeptideFigure8.png" alt="" />
 +
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 8</b>: Growth curves at 37°C of <em>E. coli</em> cells harboring the various SAIRGA expression plasmids (<a href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</a>, <a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>, <a href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</a> and <a href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</a>). The negative control has been performed with an empty pSB1C3.</figcaption>
 +
</figure>
 +
<p style="font-size:15px;">
 +
The other parts (<a href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</a>, <a href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</a> and <a href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</a>) did not show any peak at 572 Da, which suggests that the native <em>Bacillus</em> secretion tag, as well as PelB and Tat signals are not able to secrete the mature peptide. We suspect that, in each case, the pro-peptide is produced and released but its secretion tag is not cleaved by the cell.</p>
  
<h3>Gold Medal Criterion #2</h3>
+
<p style="font-size:15px;">Moreover, after 24h of incubation, we were unable to detect the SAIRGA peptide in the culturing media (Figures 9 and 10). This is probably due to the exhaustion of the medium: and the instability of the secreted peptide in the medium.</p>
<p><b>Standard Tracks:</b> Create a new part that has a functional improvement upon an existing BioBrick part. The sequences of the new and existing parts must be different. You must perform experiments with both parts to demonstrate this improvement. Document the experimental characterization on the Part's Main Page on the Registry for both the existing and new parts. Both the new and existing Main Page of each Part’s Registry entry must reference each other. Submit a sample of the new part to the Registry.
+
<figure>
 
+
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/thumb/d/d7/T--Evry_Paris-Saclay--PeptideFigure10.png/1198px-T--Evry_Paris-Saclay--PeptideFigure10.png" alt="" />
The existing part must NOT be from your 2018 part number range and must be different from the part documented in bronze #4.
+
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 9</b>: UPLC chromatogram obtained with media taken after 24h of incubation of <em>E. coli</em> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>).
 
+
</figcaption>
<br><br>
+
</figure>
<b>Special Tracks:</b> Improve the function of an existing iGEM project (that your current team did not originally create) and display your achievement on your wiki.</p>
+
<figure>
 
+
  <img style="margin-left:auto; margin-right:auto;" src="https://static.igem.org/mediawiki/2018/thumb/e/ec/T--Evry_Paris-Saclay--PeptideFigure11.png/1200px-T--Evry_Paris-Saclay--PeptideFigure11.png" alt="" />
 
+
  <figcaption style="font-size:12px;font-family: 'Nunito', sans-serif;"><b>Figure 10</b>: Mass spectrometry analysis of the media taken after 24h of incubation of <em>E. coli</em> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>).
</div>
+
</figcaption>
 +
</figure>
 +
<h2 style="font-weight:800; text-align:center;">CONCLUSION</h2>
 +
<p style="font-size:15px;">We have successfully built a part, OmpA-SAIRGA (<a href="http://parts.igem.org/Part:BBa_K2675002" target="__blank">BBa_K2675002</a>), which is able to produce and release the mature hexapeptide SAIRGA in the culturing media of <em>E. coli</em> cells harboring this part equipped with an RBS and under the control of a constitutive promoter (<a href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</a>).</p>
 +
<p style="font-size:15px;">Thus, we have made an improvement of the <a href="http://parts.igem.org/Part:BBa_K2279001" target="__blank">BBa_K2279001</a>, the SAIRGA peptide with the original secretion signal, that is not functional in <em>E. coli</em> under un equivalent transcriptional and translational control (<a href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</a>).
  
 +
<h2 style="font-weight:800; text-align:center;">REFERENCES</h2>
 +
<p style="font-size:15px;" class="bibliographie">[1] Erez Z, Steinberger-Levy I, Shamir M, Doron S, Stokar-Avihail A, Peleg Y, Melamed S, Leavitt A, Savidor A, Albeck S, Amitai G, Sorek R. Communication between viruses guides lysis-lysogeny decisions. Nature (2017) 541, 488-493.</p>
 +
<p style="font-size:15px;" class="bibliographie">[2] Espah Borujeni A, Channarasappa AS, Salis HM. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res (2014) 42, 2646-2659.</p>
 +
<p style="font-size:15px;" class="bibliographie">[3] Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol (2009) 27, 946-50.</p>
 +
<p style="font-size:15px;" class="bibliographie">[4] Hall BG. Activation of the bgl operon by adaptive mutation. Mol Biol Evol (1998) 15, 1-5.</p>
  
 
</div>
 
</div>
Line 71: Line 167:
 
<table class="direction" style="border: none; width:80%;">
 
<table class="direction" style="border: none; width:80%;">
 
   <tr>
 
   <tr>
       <th><a href="https://2018.igem.org/Team:Evry_Paris-Saclay/InterLab" style="color:black;">Previous</a></th>
+
       <th><a href="https://2018.igem.org/Team:Evry_Paris-Saclay/Design" style="color:black;">Previous</a></th>
 
       <th><img class="axel" src="https://static.igem.org/mediawiki/2018/2/2b/T--Evry_Paris-Saclay--axel_navigator_logo.png" width="100%" alt="logo axel le naviguateur"></th>
 
       <th><img class="axel" src="https://static.igem.org/mediawiki/2018/2/2b/T--Evry_Paris-Saclay--axel_navigator_logo.png" width="100%" alt="logo axel le naviguateur"></th>
 
       <th><a href="https://2018.igem.org/Team:Evry_Paris-Saclay/Model" style="color:black;">Next</a></th>
 
       <th><a href="https://2018.igem.org/Team:Evry_Paris-Saclay/Model" style="color:black;">Next</a></th>

Latest revision as of 10:43, 7 December 2018


TO CONTACT US
Genopole Campus 1, Batiment 6, 91030 Evry Cedex, France
+33 7 69 96 68 31
igemevry@gmail.com

© Copyright 2018
Design & Developpement by
IGEM EVRY GENOPOLE

THE PEPTIDE

In our system, the hexapeptide SAIRGA is the signalling molecule used for cell-to-cell communication [1]. To perform its quorum sensing function in the natural phi3T phage infection, SAIRGA needs to be secreted out of the cell. It is produced as an immature pre-pro-peptide, AimP (BBa_K2279001), that upon secretion is cleaved extracellularly to remove the secretion signal and release the mature hexapeptide. The mature peptide then re-enters cells and binds to its receptor protein AimR (BBa_K2279000). Binding of SAIRGA to AimR blocks the activator function of AimR that, in turn, facilitates a switch from lytic-to-lysogenic viral cycle. By acting as a negative regulator of AimR, the SAIRGA signal makes the lysis-to-lysogeny switch of phi3T phage dependent on the “quorum” of phi3T phages in the bacterial population.




DESIGN

In phi3T phage, SAIRGA is produced as AimP (BBa_K2279001) with specific secretion and protease-cleavage tags [1] that allow secretion and extracellular processing by Bacillus. Since we had no further information about this protease, we could not investigate the ability of Escherichia coli to produce a similar enzyme. Consequently, to produce SAIRGA in E. coli, we decided to replace this tag by an E. coli secretion signal. We have investigated three different secretion signals: OmpA (BBa_K208003), PelB (BBa_J32015) and Tat of csp2 gene of Corynebacterium glutamicum (Uniprot Q04985).

To express them in E. coli, we codon optimized all sequences for E. coli DH5α, designed specific RBSs with the Salis Lab RBS Calculator [2, 3] and placed these peptides under the control of the constitutive strong promoter BBa_J23100. Thus, we generated four SAIRGA expression plasmids (BBa_K2675041, BBa_K2675042, BBa_K2675043 and BBa_K2675044).

Part Name Translated CDS Sequence Part Number Expression Cassette Part Number
AimP MKKVFFGLVILTALAISFVAGQQSVSTASASDEVTVASAIRGA BBa_K2675001 BBa_K2675041
OmpA-SAIRGA MKKTAIAIAVALAGFATVAQASAIRGA BBa_K2675002 BBa_K2675042
PelB-SAIRGA MKYLLPTAAAGLLLLAAQPAMASAIRGA BBa_K2675003 BBa_K2675043
Tat-SAIRGA MFNNRIRTAALAGAIAISTAASGVAIPAFASAIRGA BBa_K2675004 BBa_K2675044

EXPERIMENTAL SETUP

E. coli DH5α harboring the SAIRGA expression plasmids were grown at 37°C in mineral salts medium [4] containing 2 mg/mL glucose and 35 μg/mL chloramphenicol (Figure 8). During the culturing, samples were prelevated, centrifuged and the supernatant was first sterilised by filtering through a 0.22 µm membrane, then loaded on a Pall Nanosep centrifugal device with Omega membrane (MWCO 3 kDa). The low molecular weight fraction of the culturing media thus recovered was analysed by LC-MS: ultra high pressure liquid column chromatography (UPLC) on a ACQUITY HSS T3 1.8 µM, 2.1 x 100 mm column (Waters) coupled with a Xevo G2-S Qtof mass spectrometer (Waters). The chromatography was performed using a gradient of using a (A) 1% formic acid in whater / (B) 1% formic acid in acetonitrile with the following program: from 0 to 5 min solvent B was increased from 2% to 70%, then it was maintained for 1 min at 70%; aftrewards it was decreased in 30 sec to 2% and it was maintained at 2% for 3.5 min for column re-equilibration. The flow rate was 0.2 mL/min and the column temperature was set to 45°C. The ions were detected in resolution negative mode.

The pure synthetic SAIRGA peptide was readily detected by LC-MS. As shown in Figures 1 and 2, a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- was observed at a retention time of 3.9 min (Figure 3). The area under the curve is proportional to the concentration of SAIRGA (Figure 4).

Figure 1: Mass spectrometry analysis of SAIRGA’s fraction obtained with various amounts of pure synthetic SAIRGA peptide.
Figure 2: Mass spectrometry analysis of SAIRGA’s fraction obtained with 5 µM of pure synthetic SAIRGA peptide (zoom on SAIRGA’s peak).
Figure 3: UPLC chromatograms obtained with various amount of pure synthetic SAIRGA peptide.
Figure 4: Standard curve of the area under the curve obtained by UPLC as a function of the concentration of SAIRGA.

RESULTS

LC-MS analysis of samples isolated from the fermentation broth of the E. coli strains harbouring a SAIRGA expression plasmid was performed.

As shown in Figures 5 and 6, the expression vector of OmpA-SAIRGA (BBa_K2675042) is able to produce a compound with a monoisotopic mass a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- at a retention time of 3.9 min. The size or the area under the peak is increasing with time (figure 7). This suggests that OmpA is an efficient E. coli secretion tag which allows the release of the mature peptide SAIRGA in the culturing media.

Figure 5: Mass spectrometry of culturing media taken after 2, 4, 6 and 8 hours of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042). The negative control has been performed with an empty pSB1C3 (bottom red chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.
Figure 6: UPLC chromatograms of culturing media taken after 2, 4, 6 and 8 hours of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042). The negative control has been performed with an empty pSB1C3 (bottom green chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.
Figure 7: SAIRGA production at 37°C by E. coli cells harboring the various SAIRGA expression plasmids (BBa_K2675041, BBa_K2675042, BBa_K2675043 and BBa_K2675044). The negative control has been performed with an empty pSB1C3.
Figure 8: Growth curves at 37°C of E. coli cells harboring the various SAIRGA expression plasmids (BBa_K2675041, BBa_K2675042, BBa_K2675043 and BBa_K2675044). The negative control has been performed with an empty pSB1C3.

The other parts (BBa_K2675041, BBa_K2675043 and BBa_K2675044) did not show any peak at 572 Da, which suggests that the native Bacillus secretion tag, as well as PelB and Tat signals are not able to secrete the mature peptide. We suspect that, in each case, the pro-peptide is produced and released but its secretion tag is not cleaved by the cell.

Moreover, after 24h of incubation, we were unable to detect the SAIRGA peptide in the culturing media (Figures 9 and 10). This is probably due to the exhaustion of the medium: and the instability of the secreted peptide in the medium.

Figure 9: UPLC chromatogram obtained with media taken after 24h of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042).
Figure 10: Mass spectrometry analysis of the media taken after 24h of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042).

CONCLUSION

We have successfully built a part, OmpA-SAIRGA (BBa_K2675002), which is able to produce and release the mature hexapeptide SAIRGA in the culturing media of E. coli cells harboring this part equipped with an RBS and under the control of a constitutive promoter (BBa_K2675042).

Thus, we have made an improvement of the BBa_K2279001, the SAIRGA peptide with the original secretion signal, that is not functional in E. coli under un equivalent transcriptional and translational control (BBa_K2675041).

REFERENCES

[1] Erez Z, Steinberger-Levy I, Shamir M, Doron S, Stokar-Avihail A, Peleg Y, Melamed S, Leavitt A, Savidor A, Albeck S, Amitai G, Sorek R. Communication between viruses guides lysis-lysogeny decisions. Nature (2017) 541, 488-493.

[2] Espah Borujeni A, Channarasappa AS, Salis HM. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res (2014) 42, 2646-2659.

[3] Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol (2009) 27, 946-50.

[4] Hall BG. Activation of the bgl operon by adaptive mutation. Mol Biol Evol (1998) 15, 1-5.